PharmaCorp Rx Inc. (TSXV:PCRX)

Market Cap	77.81M +38.2%
Revenue (ttm)	27.41M +97.1%
Net Income	-1.07M
EPS	-0.01
Shares Out	196.98M
PE Ratio	n/a
Forward PE	23.65
Dividend	n/a
Ex-Dividend Date	n/a

Volume	84,683
Open	0.3900
Previous Close	0.3950
Day's Range	0.3900 - 0.4000
52-Week Range	0.3750 - 0.5800
Beta	-3.95
Analysts	Buy
Price Target	0.67 (+69.62%)
Est. Earnings	Nov 18, 2026

About PharmaCorp Rx

PharmaCorp Rx Inc. operates retail pharmacies under the PharmaChoice name in Canada. The company offers prescription services; front-of-store retail, such as convenience goods, over-the-counter medications, health products, and wellness items; custom compounding; specialized consultations; and lifestyle programs. PharmaCorp Rx Inc. was incorporated in 2021 and is headquartered in Saskatoon, Canada.

• Industry: Pharmaceutical Retailers
• Sector: Healthcare
• Founded: 2021
• Country: Canada
• Stock Exchange: TSX Venture Exchange
• Ticker Symbol: PCRX

Financial Performance

In 2025, PharmaCorp Rx's revenue was 20.89 million, an increase of 260.57% compared to the previous year's 5.79 million. Losses were -1.48 million, 46.3% more than in 2024.

Analyst Summary

According to 3 analysts, the average rating for PCRX stock is "Buy." The 12-month stock price target is $0.67, which is an increase of 69.62% from the latest price.

Price Target

$0.67

(69.62% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence and QUODD

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by QUODD.

Last checked:

Nov 9, 2026

Data Sources Report a data error